JOHNSON LORIN K 4
4 · 9 METERS BIOPHARMA, INC. · Filed Jul 2, 2020
Insider Transaction Report
Form 4
JOHNSON LORIN K
Director
Transactions
- Conversion
Common stock
2020-06-30+84,800→ 84,800 total - Conversion
Series A Convertible Preferred Stock
2020-06-30−848→ 0 totalFrom: 2020-05-04→ Common stock (84,800 underlying)
Footnotes (1)
- [F1]The Series A Convertible Preferred Stock automatically converted to common stock on a 1-to-100 basis upon approval by the Company's stockholders on June 30, 2020.